Colgate-Palmolive
$84.53Change from previous close: −0.93%Absolute change: −$0.79
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- $67.39B
- Enterprise value
- $74.12B
- P/E (trailing 12 months)
- 33.3
- Forward P/E
- 20.6
- PEG
- 1.55
- Price/book
- 285.6
- Price/sales
- 3.20
- EV/EBITDA
- 14.9
- EV/revenue
- 3.52
Profitability and growth
- Gross margin
- 60.4%
- Operating margin
- 21.0%
- Net margin
- 9.7%
- ROE
- 267.4%
- ROA
- 15.8%
- Revenue growth (year over year)
- 4.9%
- Earnings growth (year over year)
- -5.5%
Financial health
- Total cash
- $1.45B
- Total debt
- $7.86B
- Debt/equity
- 13.9
- Current ratio
- 1.03
- Quick ratio
- 0.56
Dividends
- Annual dividend per share
- $2.12
- Dividend yield
- 2.5%
- Payout ratio
- 82.3%
- Ex-dividend date
- October 20, 2026
Analysts and estimates
- Average price target
- $98.60
- Median price target
- $100.00
- High price target
- $110.00
- Low price target
- $87.00
- Analysts with a price target
- 20
- Consensus
- Buy
- Forward EPS
- $4.10
- EPS estimate, current year
- $3.87
Shares and trading
- Beta
- 0.32
- Average volume
- 4.7M
- Shares outstanding
- 797.17M
- Float
- 748.35M
- Institutional ownership
- 86.4%
- Insider ownership
- 0.2%
- Short interest (% of float)
- 2.6%
- Short ratio (days)
- 4.23